On December 6, 2021, New York City announced a vaccine mandate for all private-sector employers that will take effect on December 27, 2021.

On October 25, 2023, the Federal Energy Regulatory Commission (FERC) issued an order extending the deadline for Transmission Providers to submit compliance...

Foley Hoag Partner and Senior Policy Director Basil Seggos recently spoke with Utility Dive on the uncertainty facing the energy sectorfollowing back-to-back U.S. Supreme Court decisions...

As the clock ticks toward Inauguration Day, the future of key clean energy funding programs under the Inflation Reduction Act and Bipartisan Infrastructure Law is uncertain.

The opening quarter of 2026 brought a noticeable cooling in mid-market life sciences venture activity, with deal volume dropping significantly from prior periods.

Private fund managers are reminded that the Corporate Transparency Act (CTA) may trigger reporting obligations to the Department of the Treasury's Financial Crimes Enforcement Network for private fund managers...

At the beginning of the Covid pandemic, legislation ensured that Medicaid beneficiaries would remain enrolled until the public health emergency ended.

Foley Hoag partner Ross Margulies recently joined the 340B Unscripted podcast for a discussion on the "Chevron Doctrine and 340B." In the episode, Ross provides background on Chevron deference...

On January 7, 2021, Secretary Azar of the U.S. Department of Health and Human Services extended the existing public health emergency for 90 days, until April 21, 2021.

With apologies to John Donne, ask not for whom the bells tolls, HIPAA business associates, it tolls for thee!

Edo Banach and Caroline Farrell reunite as colleagues at Foley Hoag after first meeting as Affordable Care Act hires at CMS, bringing their combined expertise in Medicaid enrollment, dual-eligible populations, and hospice care to examine the forces reshaping American healthcare. They identify coverage preservation amid Medicaid changes and Medicare's pivot toward home and community-based non-medical supports as the two defining themes that will dominate the next decade of healthcare policy.

Companies in the drug, biologic and medical device spaces may encounter compliance challenges, some of which can lead to government enforcement actions and potential civil, and even criminal, liability.

Are you a university or non-profit who's curious about the ways to unlock the potential of your incoming life sciences product royalty streams? In our comprehensive guide...

Are you a university or non-profit who's curious about the ways to unlock the potential of your incoming life sciences product royalty streams?

Senior Policy Director Connie Garner recently spoke on One Country's Hot Dish Podcast where she discussed the critical issue of mental health in rural areas. Connie, a longtime advocate for mental health parity.

On Friday, November 20, 2020, 60 calendar days prior to the inauguration of President-Elect Biden, the Trump administration released three rulemakings with significant implications for life sciences companies and healthcare providers.

Foley Hoag partner Colin Zick weighs in on large health systems putting substantial resources into IT.

In the last two years, pharmaceutical companies have begun to offer innovative warranty programs for certain therapies as a means of promoting patient access.

How do companies develop, protect, and enforce their brands and content across the ever-growing landscapes of Web 3.0? Lawyers from Foley Hoag's Trademark, Copyright & Unfair Competition...

Foley Hoag partner and Co-Chair of the firm's Privacy and Data Security Practice, offers his insights